Previous 10 | Next 10 |
Thinly traded micro cap Evofem Biosciences ( EVFM +13.2% ) is up on modestly higher volume, albeit on turnover of only 25K shares, in apparent response to its $80M capital raise that it will use to push birth control gel Amphora over the finish line and prepare for commercial launch. M...
SAN DIEGO , April 11, 2019 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) ("Evofem"), today announced it has entered into a securities purchase agreement pursuant to which Evofem can raise up to $80 million through a private placement of common stock from new and existing ...
The following slide deck was published by PDL BioPharma, Inc. in conjunction with this Read more ...
INCLINE VILLAGE, Nev. , March 26, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that Dominique Monnet , PDL's president and chief executive officer, and Peter Garcia , PDL's chief financial officer, will present at the H.C. Wainwright &a...
Spearheaded with a $100 million buyback program, PDL BioPharma ( PDLI ) had a nearly 40% run up from September until the end of March. At this point, I am taking one-third of profits. There are both fundamental and technical reasons to believe that PDL BioPharma may have reached a near-term hi...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Interest rates are back in the spotlight with a Federal Reserve interest rate decis...
PDL BioPharma, Inc. (PDLI) Q4 2018 Results Earnings Conference Call March 14, 2019, 04:30 PM ET Company Participants Jody Cain - Investor Relations Dominique Monnet - President and CEO Peter Garcia - Vice President and Chief Financial Officer Conference Call Participants Ph...
PDL BioPharma (NASDAQ: PDLI ) Q4 result s: Revenues: $45.1M (-33.7%), drop mainly due to lower royalties from Glumetza. More news on: PDL BioPharma, Inc., Healthcare stocks news, Read more ...
The following slide deck was published by PDL BioPharma, Inc. in conjunction with their 2018 Q4 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
Price matters most to making money in the market. Celebrating 20 years, Stock Traders Daily provides the tools that help you develop investment strategies, and this is a good example. When we couple this with our market based analysis, the probabilities of going with the flow increases, and t...
PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement with Wellstat RENO, Nev. , Dec. 14, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDL...
Penny Stocks to Watch Today Finding the best penny stocks to buy seems simple, but it takes time to identify a clear trend. We saw this week, how quickly these can breakout. We’ve also seen how quickly they can break down. So deciding what type of trading strategy you’...